​

Funding Round

Series D - Encoded Therapeutics

Series D - Encoded Therapeutics

Investment Firm

Overview

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Announced Date

Jul 22, 2020

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Google Ventures

Google Ventures

Google Ventures is a convertible_note and crowdfunding and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorMeritech Capital Partners
Participant InvestorMenlo Ventures
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners
Participant InvestorFarallon Capital Management

Round Details and Background

Encoded Therapeutics raised $135000000 on 2020-07-22 in Series D

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 26, 2019
Series C - Encoded Therapeutics
9-104.0M
Jul 22, 2020
Series D - Encoded Therapeutics
12-135.0M
Oct 01, 2014
Convertible Note - Encoded Therapeutics
1-100.0K

Recent Activity

There is no recent news or activity for this profile.